The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman

Sharon L. Mulvagh; Kerri Anne Mullen; Kara A. Nerenberg; Amy A. Kirkham; Courtney R. Green; Abida R. Dhukai; Jasmine Grewal; Marsha Hardy; Paula J. Harvey; Sofia B. Ahmed; Donna Hart; Anna L.E. Levinsson; Monica Parry; Heather J.A. Foulds; Christine Pacheco; Sandra M. Dumanski; Graeme Smith; Colleen M. Norris

doi:10.1016/j.cjco.2021.09.013

The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman

Sharon L. Mulvagh, Kerri Anne Mullen, Kara A. Nerenberg, Amy A. Kirkham, Courtney R. Green, Abida R. Dhukai, Jasmine Grewal, Marsha Hardy, Paula J. Harvey, Sofia B. Ahmed, Donna Hart, Anna L.E. Levinsson, Monica Parry, Heather J.A. Foulds, Christine Pacheco, Sandra M. Dumanski, Graeme Smith, Colleen M. Norris

Medicine

Résultat de recherche: Review article › examen par les pairs

33 Citations (Scopus)

Résumé

Women have unique sex- and gender-related risk factors for cardiovascular disease (CVD) that can present or evolve over their lifespan. Pregnancy-associated conditions, polycystic ovarian syndrome, and menopause can increase a woman's risk of CVD. Women are at greater risk for autoimmune rheumatic disorders, which play a role in the predisposition and pathogenesis of CVD. The influence of traditional CVD risk factors (eg, smoking, hypertension, diabetes, obesity, physical inactivity, depression, anxiety, and family history) is greater in women than men. Finally, there are sex differences in the response to treatments for CVD risk and comorbid disease processes. In this Atlas chapter we review sex- and gender-unique CVD risk factors that can occur across a woman's lifespan, with the aim to reduce knowledge gaps and guide the development of optimal strategies for awareness and treatment.

Langue d'origine	English
Pages (de-à)	115-132
Nombre de pages	18
Journal	CJC Open
Volume	4
Numéro de publication	2
DOI	https://doi.org/10.1016/j.cjco.2021.09.013
Statut de publication	Published - févr. 2022

Note bibliographique

Funding Information:
The authors gratefully acknowledge Lisa Comber for her ongoing coordination of this Atlas. A special thanks goes to Alexa Desjarlais from the University of Calgary and Manu Sandhu and Angela Poitras from the University of Ottawa Heart Institute for their graphic design of the central chapter illustration. Thanks to Manu Sandhu for graphic design of Figure 2. This article has been submitted on behalf of the CWHHA, a pan-Canadian network of approximately 100 clinicians, scientists, allied health professionals, program administrators, and patient partners, whose aim is to develop and disseminate evidence-informed strategies to transform clinical practice and enhance collaborative action on women's CV health in Canada. The CWHHA is powered by the Canadian Women's Heart Health Centre at the University of Ottawa Heart Institute. Supported by the University of Ottawa Heart Institute Foundation. S.L.M. is a member of the Novo Nordisk SOUL trial steering committee. A.L.E.L. has received grants from Astra Zeneca. The remaining authors have no conflicts of interest to disclose.

Publisher Copyright:
© 2021 The Authors

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

Journal Article
Review

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.cjco.2021.09.013

Autres fichiers et liens

Empreinte numérique

Plonger dans les sujets de recherche 'The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman'. Ensemble, ils forment une empreinte numérique unique.

Citer

Mulvagh, S. L., Mullen, K. A., Nerenberg, K. A., Kirkham, A. A., Green, C. R., Dhukai, A. R., Grewal, J., Hardy, M., Harvey, P. J., Ahmed, S. B., Hart, D., Levinsson, A. L. E., Parry, M., Foulds, H. J. A., Pacheco, C., Dumanski, S. M., Smith, G., & Norris, C. M. (2022). The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman. CJC Open, 4(2), 115-132. https://doi.org/10.1016/j.cjco.2021.09.013

The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman. / Mulvagh, Sharon L.; Mullen, Kerri Anne; Nerenberg, Kara A. et al.
Dans: CJC Open, Vol. 4, N° 2, 02.2022, p. 115-132.

Résultat de recherche: Review article › examen par les pairs

Mulvagh, SL, Mullen, KA, Nerenberg, KA, Kirkham, AA, Green, CR, Dhukai, AR, Grewal, J, Hardy, M, Harvey, PJ, Ahmed, SB, Hart, D, Levinsson, ALE, Parry, M, Foulds, HJA, Pacheco, C, Dumanski, SM, Smith, G & Norris, CM 2022, 'The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman', CJC Open, vol. 4, n° 2, pp. 115-132. https://doi.org/10.1016/j.cjco.2021.09.013

@article{cc6d6313987d4e8ea7305a933607b11c,

title = "The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman",

abstract = "Women have unique sex- and gender-related risk factors for cardiovascular disease (CVD) that can present or evolve over their lifespan. Pregnancy-associated conditions, polycystic ovarian syndrome, and menopause can increase a woman's risk of CVD. Women are at greater risk for autoimmune rheumatic disorders, which play a role in the predisposition and pathogenesis of CVD. The influence of traditional CVD risk factors (eg, smoking, hypertension, diabetes, obesity, physical inactivity, depression, anxiety, and family history) is greater in women than men. Finally, there are sex differences in the response to treatments for CVD risk and comorbid disease processes. In this Atlas chapter we review sex- and gender-unique CVD risk factors that can occur across a woman's lifespan, with the aim to reduce knowledge gaps and guide the development of optimal strategies for awareness and treatment.",

author = "Mulvagh, {Sharon L.} and Mullen, {Kerri Anne} and Nerenberg, {Kara A.} and Kirkham, {Amy A.} and Green, {Courtney R.} and Dhukai, {Abida R.} and Jasmine Grewal and Marsha Hardy and Harvey, {Paula J.} and Ahmed, {Sofia B.} and Donna Hart and Levinsson, {Anna L.E.} and Monica Parry and Foulds, {Heather J.A.} and Christine Pacheco and Dumanski, {Sandra M.} and Graeme Smith and Norris, {Colleen M.}",

note = "Funding Information: The authors gratefully acknowledge Lisa Comber for her ongoing coordination of this Atlas. A special thanks goes to Alexa Desjarlais from the University of Calgary and Manu Sandhu and Angela Poitras from the University of Ottawa Heart Institute for their graphic design of the central chapter illustration. Thanks to Manu Sandhu for graphic design of Figure 2. This article has been submitted on behalf of the CWHHA, a pan-Canadian network of approximately 100 clinicians, scientists, allied health professionals, program administrators, and patient partners, whose aim is to develop and disseminate evidence-informed strategies to transform clinical practice and enhance collaborative action on women's CV health in Canada. The CWHHA is powered by the Canadian Women's Heart Health Centre at the University of Ottawa Heart Institute. Supported by the University of Ottawa Heart Institute Foundation. S.L.M. is a member of the Novo Nordisk SOUL trial steering committee. A.L.E.L. has received grants from Astra Zeneca. The remaining authors have no conflicts of interest to disclose. Publisher Copyright: {\textcopyright} 2021 The Authors",

year = "2022",

month = feb,

doi = "10.1016/j.cjco.2021.09.013",

language = "English",

volume = "4",

pages = "115--132",

journal = "CJC Open",

issn = "2589-790X",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4

T2 - Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman

AU - Mulvagh, Sharon L.

AU - Mullen, Kerri Anne

AU - Nerenberg, Kara A.

AU - Kirkham, Amy A.

AU - Green, Courtney R.

AU - Dhukai, Abida R.

AU - Grewal, Jasmine

AU - Hardy, Marsha

AU - Harvey, Paula J.

AU - Ahmed, Sofia B.

AU - Hart, Donna

AU - Levinsson, Anna L.E.

AU - Parry, Monica

AU - Foulds, Heather J.A.

AU - Pacheco, Christine

AU - Dumanski, Sandra M.

AU - Smith, Graeme

AU - Norris, Colleen M.

N1 - Funding Information: The authors gratefully acknowledge Lisa Comber for her ongoing coordination of this Atlas. A special thanks goes to Alexa Desjarlais from the University of Calgary and Manu Sandhu and Angela Poitras from the University of Ottawa Heart Institute for their graphic design of the central chapter illustration. Thanks to Manu Sandhu for graphic design of Figure 2. This article has been submitted on behalf of the CWHHA, a pan-Canadian network of approximately 100 clinicians, scientists, allied health professionals, program administrators, and patient partners, whose aim is to develop and disseminate evidence-informed strategies to transform clinical practice and enhance collaborative action on women's CV health in Canada. The CWHHA is powered by the Canadian Women's Heart Health Centre at the University of Ottawa Heart Institute. Supported by the University of Ottawa Heart Institute Foundation. S.L.M. is a member of the Novo Nordisk SOUL trial steering committee. A.L.E.L. has received grants from Astra Zeneca. The remaining authors have no conflicts of interest to disclose. Publisher Copyright: © 2021 The Authors

PY - 2022/2

Y1 - 2022/2

N2 - Women have unique sex- and gender-related risk factors for cardiovascular disease (CVD) that can present or evolve over their lifespan. Pregnancy-associated conditions, polycystic ovarian syndrome, and menopause can increase a woman's risk of CVD. Women are at greater risk for autoimmune rheumatic disorders, which play a role in the predisposition and pathogenesis of CVD. The influence of traditional CVD risk factors (eg, smoking, hypertension, diabetes, obesity, physical inactivity, depression, anxiety, and family history) is greater in women than men. Finally, there are sex differences in the response to treatments for CVD risk and comorbid disease processes. In this Atlas chapter we review sex- and gender-unique CVD risk factors that can occur across a woman's lifespan, with the aim to reduce knowledge gaps and guide the development of optimal strategies for awareness and treatment.

AB - Women have unique sex- and gender-related risk factors for cardiovascular disease (CVD) that can present or evolve over their lifespan. Pregnancy-associated conditions, polycystic ovarian syndrome, and menopause can increase a woman's risk of CVD. Women are at greater risk for autoimmune rheumatic disorders, which play a role in the predisposition and pathogenesis of CVD. The influence of traditional CVD risk factors (eg, smoking, hypertension, diabetes, obesity, physical inactivity, depression, anxiety, and family history) is greater in women than men. Finally, there are sex differences in the response to treatments for CVD risk and comorbid disease processes. In this Atlas chapter we review sex- and gender-unique CVD risk factors that can occur across a woman's lifespan, with the aim to reduce knowledge gaps and guide the development of optimal strategies for awareness and treatment.

UR - http://www.scopus.com/inward/record.url?scp=85123106298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123106298&partnerID=8YFLogxK

U2 - 10.1016/j.cjco.2021.09.013

DO - 10.1016/j.cjco.2021.09.013

M3 - Review article

C2 - 35198930

AN - SCOPUS:85123106298

SN - 2589-790X

VL - 4

SP - 115

EP - 132

JO - CJC Open

JF - CJC Open

IS - 2

ER -